Skip to main content

Peer Review reports

From: Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics

Original Submission
20 Dec 2020 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Jan 2021 Reviewed Reviewer Report
14 Mar 2021 Reviewed Reviewer Report
1 Apr 2021 Author responded Author comments - Xixian Ke
Resubmission - Version 3
1 Apr 2021 Submitted Manuscript version 3
29 Apr 2021 Author responded Author comments - Xixian Ke
Resubmission - Version 4
29 Apr 2021 Submitted Manuscript version 4
1 May 2021 Reviewed Reviewer Report
12 May 2021 Author responded Author comments - Xixian Ke
Resubmission - Version 5
12 May 2021 Submitted Manuscript version 5
Publishing
17 May 2021 Editorially accepted
26 May 2021 Article published 10.1186/s12885-021-08378-3

You can find further information about peer review here.

Back to article page